Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Kamada

Market Cap: ₪1.4b

Manufactures and sells plasma-derived protein therapeutics.

Ventyx Biosciences

Market Cap: US$108.9m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Vaxcyte

Market Cap: US$4.4b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Nanoform Finland Oyj

Market Cap: €83.0m

Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

Stevanato Group

Market Cap: US$6.5b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Cizzle Biotechnology Holdings

Market Cap: UK£6.5m

Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.

LENZ Therapeutics

Market Cap: US$792.5m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Barinthus Biotherapeutics

Market Cap: US$33.4m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

Silence Therapeutics

Market Cap: US$242.8m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Lytix Biopharma

Market Cap: NOK 546.1m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

MacroGenics

Market Cap: US$94.0m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

Boundless Bio

Market Cap: US$37.2m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Fusion Antibodies

Market Cap: UK£7.8m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Revolution Medicines

Market Cap: US$7.2b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

HilleVax

Market Cap: US$94.3m

A clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.

Exicure

Market Cap: US$69.5m

Does not have significant operations.

Tourmaline Bio

Market Cap: US$388.2m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Synlogic

Market Cap: US$13.3m

A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.

Protara Therapeutics

Market Cap: US$125.4m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Newbury Pharmaceuticals

Market Cap: SEK 70.9m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

PCI Biotech Holding

Market Cap: NOK 59.7m

A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.

ProKidney

Market Cap: US$221.3m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Medicure

Market Cap: CA$9.8m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Exelixis

Market Cap: US$11.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ADMA Biologics

Market Cap: US$4.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Corcept Therapeutics

Market Cap: US$8.0b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Biogen

Market Cap: US$18.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

AFT Pharmaceuticals

Market Cap: NZ$283.1m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Intellia Therapeutics

Market Cap: US$953.0m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

XORTX Therapeutics

Market Cap: CA$5.5m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Blau Farmacêutica

Market Cap: R$2.5b

A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

Monopar Therapeutics

Market Cap: US$217.4m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.